Carla Greenbaum, MD
Benaroya Research Institute · Type 1 Diabetes TrialNet · Benaroya Research Institute at Virginia Mason
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carla Greenbaum, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT05847413 · Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1DBenaroya Research Institute · completed · Type 1 Diabetes · principal investigator
- Ph2NCT04729296 · Anti-TNFα to Delay or Prevent Progression to Stage 3 T1DNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · withdrawn · Diabetes Mellitus, Type 1 · study chair
- Ph1NCT04279613 · A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Type I Diabetes · study director
- Early Ph1NCT04118153 · Early Markers of Disease and Response to TherapySandra Lord, MD · completed · Type 1 Diabetes · principal investigator
- Early Ph1NCT03632759 · Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1DCarla Greenbaum, MD · completed · Type 1 Diabetes Mellitus · principal investigator
- Ph2NCT03428945 · Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · terminated · Type1 Diabetes Mellitus · study chair
- Ph2NCT03396484 · Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 DiabetesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · withdrawn · Type1 Diabetes Mellitus · study chair
- Early Ph1NCT02641522 · Modulation of STAT3 Signaling With Siltuximab in Type 1 DiabetesCarla Greenbaum, MD · completed · Type 1 Diabetes · principal investigator
- Ph2NCT02580877 · Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Type 1 Diabetes · study chair
- Ph1NCT00525889 · Proleukin and Rapamune in Type 1 DiabetesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Diabetes Mellitus, Type 1 · principal investigator
- Ph2NCT00279305 · Rituximab in New Onset Type 1 DiabetesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Type 1 Diabetes Mellitus · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Data Coordinating Center for Type 1 Diabetes TrialNetU01DK106993 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER, SAMUEL S WU · fiscal years 2019 to 2026Named on NCT04729296
- Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3UC4DK117009 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2017 to 2019
- NIDDK Type 1 Diabetes TrialNet Data Coordinating CenterUC4DK106993 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI JEFFREY P KRISCHER · fiscal years 2015
- Type 1 Diabetes Trialnet: Operations Coord. CenterU01DK061055 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JOHN M LACHIN · fiscal years 2001 to 2008Named on NCT00279305
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.